Wednesday, May 22, 2019

Locana Finds $55M For Gene Therapy

San Diego-based Locana, a developer of RNA-targeting gene therapy technology, announced Wednesday morning that it has raised $55M in a Series A funding round. The funding was led by ARCH Venture Partners, and also included Temasek and Lightstone Ventures, along with new investors UCB Ventures and GV (formerly Google Ventures). According to Locana, the

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.

---